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Abstract
Biofilm formation conferring pathogenicity is a survival strategy for Pseudomonas aeruginosa. P. aeruginosa’s virulence 
may differ due to differences in host-microbe interactions and the growth environment. The epithelial cell line within the 
respiratory system and the keratinocytes on the skin form the first physical barrier of defence. P. aeruginosa spp. biofilm 
formation and virulence factor secretion with and without quorum quenching (QQ) treatment was studied in co-culture 
using A549 and HaCaT cell lines; pyocyanin and rhamnolipid productions and elastolytic activity as virulence factors were 
quantified by independent assays. Biofilm formation was evaluated under dynamic conditions by quantifying total carbo-
hydrates, alginate, proteins and eDNA. A sandwich ELISA was performed to study IL-8 secretion by the epithelial cells. 
The difference in gene expression of the quorum sensing (QS) and virulence factors between strains during individual and 
combination treatments was analysed by qPCR. Combination treatment by farnesol and tyrosol was more effective against 
P. aeruginosa biofilms when grown in co-cultures. The strain RBHi was found to be 3 to 4 times more virulent compared 
to PAO1 and NCTC 10,662, respectively, and combination treatment was more effective against RBHi strain when grown 
in co-culture with A549 cell line. The addition of quorum quenchers (QQs) individually and in combination reduced IL-8 
secretion by A549 cells. Relative mRNA expression showed upregulation of the QS genes and virulence factors. Co-culture 
of P. aeruginosa and HaCaT cell line showed a general decrease in gene expression, especially in the case of P. aeruginosa 
RBHi when treated with farnesol and tyrosol combination.
Key points
• Differentiating the interactions of biofilm formed by different phenotypes of P. aeruginosa, NCTC 10,662 (non-mucoid), 
PAO1 (semi mucoid) and RBHi (heavily mucoid).
• Biofilm formed by these P. aeruginosa strains on two commonly afflicted tissues represented by A549 (lung) and HaCaT 
(skin) cell lines.
• Anti-biofilm/anti-virulence roles of quorum quenchers, tyrosol and farnesol in co-cultures.
Keywords Quorum quenchers · Farnesol · Tyrosol · Pseudomonas aeruginosa · Acyl-homoserine lactones · Biofilms
Introduction
The Gram-negative bacterium, Pseudomonas aeruginosa, 
is a well-known opportunistic pathogen that causes geneti-
cally inherited human cystic fibrosis (CF). During chronic 
infections in CF airways, it is common for the bacterium 
to acquire selective phenotypes that aid its survival within 
the environment of the human lung in the presence of toxic, 
osmotic and oxidative stress induced by the host immune 
system (Camus et al. 2021). Literature has documented that 
in such a scenario, a primary selective phenotypic change 
is the production of alginate that envelops the bacteria 
(mucoid). This results in sticky mucus, most notably in the 
respiratory tract of CF patients making them susceptible to 
chronic lung infections and the high rate of morbidity and 
mortality associated with CF (Bhagirath et al. 2016).
The presence of non-mucoid, mucoid, and strongly 
mucoid strains of P. aeruginosa highlights the variety of 
genetic variation in this pathogenic bacterium (Workentine 
et al. 2013). P. aeruginosa’s ability to form biofilms, which 
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is regulated by its ability to coordinate gene expression via 
the cell density-dependent mechanism of quorum sensing 
(QS), is the key virulence factor that causes chronic infec-
tions (Sousa and Pereira 2014). The ability of P. aeruginosa 
to form biofilms varies between strains and is reflected in 
the extracellular polymeric substances (EPS) composition 
and biofilm structure, which is affected by growth condi-
tions and nutrient availability. In addition to external stimuli, 
the presence or absence of ancillary factors such as flagella, 
fimbriae and polysaccharide matrix production may influ-
ence the growth of biofilms and define their total biomass 
(Berne et al. 2015).
When considering the role of QS in pathogenic bacteria 
in the development of novel antibacterial therapies, the fol-
lowing QS-mediated features that make the pathogen resil-
ient must be noted: colonisation, adhesion, acid tolerance, 
biofilm formation, motility, sporulation and other virulence 
factors vary by bacterial species (Rutherford and Bassler 
2012; Obana et al. 2014; Abisado et al. 2018).
P. aeruginosa can adapt and survive in a number of envi-
ronmental niches due to the existence of various regulatory 
proteins. The diversity of virulence factors (toxins) released 
by P. aeruginosa and its ability to form robust biofilms are 
important considerations (Moradali et al. 2017a, b). Bio-
film formation along with secreted toxins aids P. aeruginosa 
in circumventing the immune response of the host (Moser 
et al. 2017). Each individual virulence factor plays a role 
in the pathogenesis of P. aeruginosa; for instance, elastase 
degrades the extracellular matrix proteins of epithelial cells 
and disrupts the blood vessels (Xu and Shi 2014), rham-
nolipids promote invasion of P. aeruginosa by disrupting the 
host tissue (Alhazmi 2015), and pyocyanin inhibits cellular 
respiration (Hall et al. 2016).
The prevalence of certain virulence factors may change 
with the localisation of the infection in the host tissue by P. 
aeruginosa (Gellatly and Hancock 2013). As a result, P. aer-
uginosa pathogenesis is commonly linked to the expression 
and synthesis of a variety of cell-associated and extracellular 
virulence factors mediated by QS. In general, virulence of 
P. aeruginosa can be differentiated between non-mucoid, 
mucoid and strongly mucoid strains, with overproduction of 
alginate (Ryall et al. 2014). The primary differentiations of 
virulence between non-mucoid and mucoid strains include 
the loss of flagella and pili affecting motility and loss of 
pigment production. Subsequently, mucoid strains of P. aer-
uginosa are able to either proliferate and cause acute infec-
tions or propagate in the case of chronic infections (Valentini 
et al. 2018).
Internalisation of bacterial cells into the epithelium is 
advantageous to the host early in the infection as it triggers 
inflammation and an immune response (Lippmann et al. 
2015). P. aeruginosa spp. are known to bind to epithelial 
cells and facilitate internalisation as a survival/defence 
mechanism against the host immune response (Lepanto 
et al. 2011). They adhere to epithelial cells with their fla-
gellum and pili and enter the cells through receptor-medi-
ated endocytosis (Cossart and Helenius 2014). According 
to studies, internalisation is critical in assisting the bacte-
ria’s survival within the host tissue by avoiding the killing 
mechanisms.
Variation in mucoid isolates from chronic lower airway 
infections is often attributed to mutations in the alginate bio-
synthesis pathway (Sousa and Pereira 2014). To undergo a 
physiological transformation into pathogenic behaviour and 
cause infections in human hosts, an environmental strain of 
P. aeruginosa must produce alginate. Alginate provides a 
stable environment for the bacteria and aids in the creation 
of a mature biofilm’s three-dimensional structure (Roy et al. 
2018). Alginate, which is predominantly found in mucoid 
strains of P. aeruginosa, is considered to be an anionic poly-
mer, rich in mannuronic acid and glucuronic acid (Limoli 
et al. 2015). A very selective phenotype of alginate overpro-
duction is observed in highly mucoid CF isolates (Limoli 
et al. 2017). Folkesson et al. (2012) found that the existence 
of sub-lethal levels of hydrogen peroxide, a product of poly-
morphonuclear neutrophils, is linked to the overproduction 
of alginate in CF isolates. In a related research, Mathee et al. 
(1999) discovered that non-mucoid strains produce/overpro-
duce alginate in the presence of hydrogen peroxide.
The development of IL-8 by epithelial cells is a key 
indicator of the host’s reaction, and it is usually linked to 
both acute and chronic infections (Shahzad et al. 2010). 
IL-8 development from host tissue is stimulated by a vari-
ety of bacterial secreted factors (Kobayashi et al. 2018). In 
the presence of  biofilm-related infections, the presence of 
flagellin and lipopolysaccharides and the continuous syn-
thesis and release of N-acyl-homoserine lactones (AHL) 
molecules, have been identified as the key causes of IL-8 
secretion by mammalian cells (Li and Tian 2012a, b).
P. aeruginosa and Candida albicans are known to coexist 
in a clinical setting and are commonly found it the respira-
tory tract in CF airways (Haiko et al. 2019). The ability to 
form biofilm by C. albicans is dictated by its propensity to 
produce QS molecules such as farnesol and tyrosol (Mon-
teiro et al. 2017).
Farnesol and tyrosol function primarily as fungal QS 
molecules, whereby they aid in regulating the gene expres-
sion and help coordinate collective behaviour of fungi to 
thrive in their niche (Rodrigues and Černáková, 2020). As 
a fungal QS molecule, the primary function of farnesol is 
to inhibit the yeast hyphae formation in a concentration-
dependant manner, whereas tyrosol stimulates hyphae and 
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germ tube formation in a concentration-dependant manner. 
Collectively, farnesol and tyrosol function in tandem as 
required in the life cycle of the fungi to aid in fungi adhe-
sion, proliferation, filamentation and dispersal (Zawrotniak 
et al. 2019 and Rapala-Kozik et al. 2019).
Compared to abiotic surfaces, the use of cell lines allows 
for the creation of experimental designs that can address 
basic mechanical and biochemical questions to help in the 
understanding of what happens in a regulated in vitro setting. 
This could help researchers figure out what QQ does and 
how it affects QS-mediated gene expression, which facili-
tates bacterial contact and biofilm formation. There is little 
information in literature investigating the effect of QQ on 
biofilm formation by different phenotypes of P. aeruginosa 
on a biotic surface (Chien Yi 2018; Ruiyi et al. 2019; Thi 
et al. 2020). Our study made use of the A549, human lung 
carcinoma cells (Kaplan et al. 2017) and HaCaT, immortal-
ised human keratinocyte cells (Seo et al. 2012) to investigate 
for the first time the variation in biofilm formation and viru-
lence factor secretion between non-mucoid, mucoid and a 
heavily mucoid cystic fibrosis (CF) isolate of P. aeruginosa 
in the presence of QQs, farnesol and tyrosol.
In vitro studies have shown QS-mediated changes in P. 
aeruginosa in relation to regulation of gene expression, 
specifically during biofilm formation. Production of viru-
lence can be differentiated, as mentioned above, between 
non-mucoid and mucoid strains of P. aeruginosa. Further-
more, downregulation of certain virulence factors has been 
reported when comparing non-mucoid and mucoid strains of 
P. aeruginosa (Lee et al. 2005 and Moradali et al. 2017a, b).
However, most of the in vitro studies conducted so far 
do not take into consideration a scenario whereby QS mol-
ecules of other species of microorganisms coexist alongside 
P. aeruginosa in CF airways and their effect on biofilm for-
mation and QS of P. aeruginosa. Additionally, the QQ effect 
of fungal QS molecules and their inhibitory effect against 
P. aeruginosa in the presence of mammalian cell lines are 
not reported.
Analysing P. aeruginosa biofilm formation and corre-
sponding bacterial communication inhibition by (QQs) on 
mammalian cell lines will provide a better understanding 
of the phenomenon of QQ since it will enable researchers 
to test the efficacy of QQ in an environment that mimics a 
natural (biotic) surface, such as an epithelial cell line, for 
bacterial adherence and biofilm formation.
This study focuses on farnesol and tyrosol and assesses 
their ability to inhibit, as fungal QS molecules, the QS pro-
cess in P. aeruginosa, and as QQs when grown on mam-
malian cell lines.
Material and methods
Bacterial strains and preparation of bacterial 
inoculum
P. aeruginosa NCTC 10,662 (non-mucoid), P. aeruginosa 
PAO1 (semi mucoid) and P. aeruginosa RBHi (heavily 
mucoid) were selected as model phenotypes for this study.
P. aeruginosa PAO1 and P. aeruginosa NCTC 10,662 
were obtained from the University of Westminster, Lon-
don, culture collection. P. aeruginosa CF isolate was kindly 
donated by the culture collection facility at Royal Brompton 
Hospital, London, UK (referred to as RBHi in this study).
P. aeruginosa strains were subcultured into Lysogeny 
broth (LB broth) from the slants and incubated aerobically 
overnight (16–18 h) at 37 °C at 180 rpm. The absorbance 
 (OD600) of the overnight growth of P. aeruginosa sp. was 
readjusted in sterile LB broth to obtain an equivalence 
absorption according to 0.5 McFarland standards (~ 1.5 ×  108 
cells) and used for further biofilm growth. A flow cell 
(Transmission Flow cell, FC 281, BioSurface Technologies 
Corporation (BST), Montana, USA) provided a closed sys-
tem where bacterial attachment occurred and biofilm struc-
ture and hence EPS produced.
Cell culture
A549 cells were obtained from the American Type Culture 
Collection (ATCC CCL-185). HaCaT cells were obtained as 
a kind donation from Division of Surgery and Interventional 
Science, UCL, Royal free Hospital, London, UK.
A549 and HaCaT culture
A549 and HaCaT cells were seeded into either 96-well plate 
at 1 ×  104 cells per well or 6-well plate (Nunc) at 5 ×  105 cells 
per well, unless otherwise indicated. The cells were allowed 
to adhere overnight in high glucose DMEM (phenol red) 
supplemented with 10% FBS and 1 × pen strep. The plates 
were incubated at 37 °C at 5%  CO2 for a period of 4 days 
until they reached ~ 80% confluency. The wells were then 
rinsed with 1 × PBS (phosphate-buffered saline) to wash 
away dead cells and phenol red prior co-culture experiments 
and treatments.
Co‑culture of P. aeruginosa sp. with A549 and HaCaT 
cell lines
Protocol for the co-culture biofilm model was adopted from 
Moreau-Marquis et al. (2010) with a few modifications. For 
the purpose of the assays, A549 and HaCaT cells were grown 
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to confluence in 6-well tissue culture plates prior to bacterial 
inoculation. The three strains of P. aeruginosa were grown 
overnight in LB medium at 37 °C. The overnight bacterial 
growth was centrifuged at 5000 rpm to pellet the cells, and 
the supernatant containing the spent medium was discarded. 
The pellet containing the bacterial cells was resuspended in 
1 × PBS. Based on bacterial cell count and seeded A549 and 
HaCaT cells, multiplicity of infection (MOI) was approxi-
mately adjusted to 20:1, and the co-culture was incubated 
for 1 h with and without treatment involving farnesol (E, 
E–farnesol) and tyrosol (2,4-hydroxyphenyl-ethanol) (Cam-
bridge biosciences, Cambridge, UK) and  MIC50 combination 
of the two as detailed in the relevant sections below. After the 
incubation period, the A549 and HaCaT cells were rinsed, 
and adhered bacteria were quantified by spot plate analysis 
based on work done by Thomas et al (2015). The percentage 
adherence was calculated based on the ratio of adhered bacte-
ria to the number of bacteria in the inoculum. Internalisation 
assay involving the three strains followed a similar protocol as 
the adherence assay. Gentamicin at 200 mg/mL was used to 
eliminate the bacteria in suspension, and the A549 and HaCaT 
cells were lysed open.
Cell viability assay (MTT assay)
Cell viability assay was performed based on the manufactur-
er’s instructions. For the purpose of the assay, the cells were 
treated after reaching confluency (~ 3 to 4 day) for a period of 
4 h prior to performing the MTT assay. The growth medium 
from the experimental set-up from the wells (96-well plate) 
was removed and replaced with 100 μL of fresh medium. 
To the wells, 10 μL of the 12-mM MTT (Vybrant MTT Cell 
Viability Assay, Thermo Fisher Scientific) stock solution was 
added. A negative control was included by adding 10 μL of 
MTT stock solution to blank wells containing medium alone. 
After labelling the cells with MTT, 25 μL of the medium was 
removed and replaced with 50 μL of DMSO with thorough 
mixing by pipetting. The 96-well plates were then incubated 
at 37 °C and 5%  CO2 for a period of 3 h. The samples were 
mixed again prior to reading the plate at 540 nm.
The mean of three independent experiments (n = 8) was 
used to calculate the cell viability. Percentage viability was 
calculated as the ratio between untreated and treated cells 
(and in co-culture). The wells without the cells and without 
treatment were used as the negative controls and the values 
subtracted from the negative control wells and treatment 
wells prior to analysis.
Adherence and internalisation of P. aeruginosa sp. 
cells to A549 and HaCaT cells in co‑culture
The adherence and internalisation of P. aeruginosa cells 
to A549 and HaCaT cells were compared as described 
previously by Carterson et  al. (2005). To identify the 
adherence of bacterial cells, co-culture was carried out as 
described previously, with and without treatment. Following 
the required incubation time, the plates containing the A549 
and HaCaT cells were washed with 1 × PBS, and 200 mL of 
PBS-T was introduced in the wells and incubated for 30 min. 
Following incubation, the medium was then removed and 
spot plated for CFU enumeration. Percentage adherence was 
calculated based on CFU obtained from sessile cell count 
against the initial CFU of the inoculum used.
Gentamicin exclusion assay was adopted to calculate 
the internalisation of the bacteria. Following incubation, 
the external bacteria were killed using 200 mg/mL of gen-
tamicin for 2 h. Controls of A549 and HaCaT cell free wells 
were used as controls to show complete killing of exter-
nal bacteria. After 2 h, gentamicin was washed away, three 
times, by rinsing with 1 × PBS. The A549 and HaCaT cells 
were then lysed by adding 1% Triton X-100 in PBS for 1 h, 
and the plates were incubated at 37 °C. Following incuba-
tion, the medium from the plates were spot plated to obtain 
CFU counts. Percentage internalisation was calculated based 
on the CFU obtained after gentamicin treatment against the 
initial CFU count of the inoculum.
Quantification of P. aeruginosa sp. biofilm by CV 
staining method
Numerous in vitro models have been suggested to investigate 
and quantify biofilm formation (Lebeaux et al. 2013). In a 
96-well microtiter tray, 200 μL of adjusted inoculum of P. 
aeruginosa sp. was added to all test wells and 200 μL of the 
appropriate growth medium to control wells. After incuba-
tion for a period of 4 h, the wells were gently washed with 
PBS to remove unattached planktonic cells, and the appro-
priate amount of medium was re-added for biofilm growth. 
Under static conditions, the 96-well microtiter plates were 
incubated at 37 °C for a period of ~ 18 h. After incubation for 
biofilm growth, biofilm was fixed using heat fixation 60 °C 
for 60 min. Crystal violet (CV) (220 μL volume, 0.1% w/v) 
was added to each well and allowed to stain for 10 min at 
room temperature. The optical density was determined at 
570 nm using VersaMax Tunable Microplate Reader (VWR, 
Leicestershire, UK).
In order to prevent overestimation of the quantity of bio-
film, the absorbance value obtained with CV staining of the 
control A549 cells was subtracted from the experimental 
values prior to analysis. Individual negative control of A549 
cells was included in each of the experimental set-up under-
going the same treatment without the inclusion of bacterial 
cells. The same was performed for all biochemical analysis 
of biofilm components and virulence production. All experi-
ments were performed in triplicates.
8856 Applied Microbiology and Biotechnology (2021) 105:8853–8868
1 3
Analysis of EPS composition of P. aeruginosa sp. 
biofilms
Based on work conducted by Liu and Fang (2002), the pro-
tocol for formaldehyde-NaOH method of EPS extraction was 
adopted for this study with a few modifications.
Quantification of total carbohydrates The method described 
by Dubois et al. (1956) was adopted to quantify the total 
sugars present in the EPS extracted from the biofilm formed 
by P. aeruginosa. Reagents used for the total carbohydrate 
assay were phenol (80%w/v) and sulphuric acid (95.5% rea-
gent grade). Absorbance was recorded at 490 nm. A standard 
curve was prepared using glucose. A modified version of the 
phenol–sulphuric acid assay as described by Masuko et al. 
(2005) was adopted for this study due to the convenience 
of performing the protocol and also due to the numerous 
samples that needed to be analysed. The high-throughput 
nature of the assay and use of phenol and sulphuric in lim-
ited quantities were desirable.
Quantification of alginate Carbazole reaction-mediated 
quantification of uronic acid content was performed using 
D-glucuronic acid lactone as standard. A version of the assay 
based on Bitter and Muir (1962) and modified by Cesaretti 
et al. (2003) was used.
Quantification of total proteins A microtiter plate-based 
Bradford assay was adopted for this study, as modified by 
Ernst and Zor (2010). The modifications were based on 
the Bradford assay that makes use of the Coomassie bril-
liant blue stain. All experiments were performed in trip-
licates, and the experiments were repeated three times for 
reproducibility.
Quantification of eDNA eDNA content of the biofilms 
formed by P. aeruginosa sp. was quantified by a fluorometric 
assay using a dsDNA Qubit Broad-Range assay kit (Thermo 
Fisher Scientific, Dartford, UK).
Analysis of virulence factors
Quantification of elastolytic activity The elastolytic activity 
of P. aeruginosa sp. was determined using elastin Congo 
red (ECR) assay as described by Pearson et al. (1997) with 
modifications. Aliquots (100 mL) of biofilm extracts were 
added to tubes containing 20 mg ECR in 900 mL of ECR 
buffer (100 mM Tris, 1 mM  CaCl2, pH 7.5). The mixture 
was then incubated at 37 °C for a period of 3 h and incubated 
on ice after 0.1 mL of 0.1 M EDTA and was added. Insolu-
ble ECR was removed by centrifugation, and the absorbance 
of the supernatant was measured at 495 nm.
Quantification of pyocyanin Pyocyanin quantification was 
performed based on the method by Essar et al. 1990 with 
modifications. Quantification was based on absorbance of 
pyocyanin at 520 nm under acidic conditions after phase 
separation using chloroform. Biofilms were resuspended in 
1 × PBS, and 500 mL of the resuspension was extracted with 
3 mL of chloroform and re-extracted into 2 mL of 0.2 M 
HCl to provide a pink to red solution. Sample volumes 
(200 mL) were then transferred to a microtiter plate, and 
the absorbance was measured at 520 nm. The concentration 
of pyocyanin was expressed as mg/mL upon multiplying the 
absorbance at 520 nm with the molar extinction coefficient 
of 17.072 (Moayedi et al. 2017).
Quantification of pyoverdine Spectrofluorometric quantifi-
cation was performed by measuring the resuspended biofilm 
filtrate (0.22-mm filter) at 405 nm.
Quantification of rhamnolipid Quantification of rhamnolipid 
was carried out by applying the orcinol reaction as described 
by Laabei et al. (2014) with modifications. The supernatant 
was extracted 3 times with 1 mL diethyl ether prior to com-
plete evaporation under vacuum. Upon completion, 0.5 mL 
of distilled  H2O was added to each of the sample tubes. For 
the assay, 100 mL of samples was taken after resuspension 
in  dH2O. To the samples, 900 mL of 0.19 orcinol (diluted in 
53%  H2SO4) was added and incubated at 80 °C for 30 min. 
After incubation, the samples were cooled to room tempera-
ture, and the absorbance was measured at 421 nm and the 
concentration was measured based on the standard curve 
prepared using rhamnose.
IL‑8 secretion analysis in P. aeruginosa sp. Biofilm 
co‑cultured with A549 and HaCaT cells
IL-8 secretion by A549 and HaCaT cells following biofilm 
formation by P. aeruginosa sp., with and without treatment, 
was performed. Following co-culture and treatment with 
farnesol and tyrosol in 6-well plates, the supernatant of the 
co-culture was removed and stored at − 80 °C until further 
use. A sandwich ELISA was performed using the Human 
IL-8 ELISA kit (Invitrogen, Paisley, UK). Protocol followed 
was based on the manufacturer’s instruction.
qPCR analysis of QS network and virulence factors 
in P. aeruginosa co‑cultured with A549 and HaCaT 
cells
RNA extraction from bacterial cells was performed using the 
TRIzol RNA isolation protocol described by Chomczynski 
and Sacchi in 1987. cDNA preparation was then done by 
using the QuantiTect Reverse Transcription kit (Qiagen Ltd, 
Manchester, UK).
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Samples prepared by using diluted forward and reverse 
primer (Tables 1 and 2) mix (1/10 dilution) run in duplicate 
and the conditions were set as follows: Initial denaturation 
was done at 95 °C for 2 min. Subsequently, the amplification 
program involved 40 cycles of denaturation at 95 °C for 15 s, 
primer annealing at 55 °C for 15 s and extension at 72 °C 
for 30 s. A final extension was performed at 72 °C for 2 min 
followed by cooling at 4 °C. A dissociation step at 55 °C was 
used to generate a melting curve with a 1 °C increase every 
5 s until 95 °C to obtain verification of amplified product. 
Reference genes were as reported in Table 3. SYBR Green 
qPCR was performed using Rotor Gene Q (Qiagen Ltd, 
Manchester, UK).
Statistical analysis
All experiments were performed in triplicates. All data for 
assays performed in this study were statistically analysed 
using GraphPad Prism to determine p values and establish 
correlation between data sets. All graphs were plotted using 
GraphPad Prism. p < 0.05 was considered significant.
Results
P. aeruginosa sp. adherence pattern to A549 
and HaCaT cell lines with and without QQ mediated 
by farnesol and tyrosol
Cell viability assay involving MTT reagent was performed 
on A549 and HaCaT cells to see if farnesol and tyrosol dis-
played any antagonistic activity at the concentrations used. 
As A549 and HaCaT cells do not tolerate the  MIC50 of 
farnesol and tyrosol used for bacterial culture (Fig. S1a), a 
significantly lower concentration was used (Fig. S1b). MTT 
assay was performed on sub-MIC50 of farnesol (2.5 µM) and 
tyrosol (1.5 µM) as single treatments and on the sub-MIC50 
of each in combination, farnesol (1.25 µM) and tyrosol 
Table 1  Primers for QS genes 
in P. aeruginosa 
Gene Primer Nucleotide sequence Reference
lasI Forward 5′ CGT GCT CAA GTG TTC AAG G 3′ Jack et al. (2018); Zhu et al. (2004)
Reverse 5′ TAC AGT CGG AAA AGC CCA G 3′
lasR Forward 5′AAG TGG AAA ATT GGA GTG GAG 3′
Reverse 5′ GTA GTT GCC GAC GAC GAT GAAG 3′
rhlI Forward 5′ TTC ATC CTC CTT TAG TCT TCCC 3′
Reverse 5′ TTC CAG CGA TTC AGA GAG C 3′
rhlR Forward 5′ TGC ATT TTA TCG ATC AGG GC 3′
Reverse 5′ CAC TTC CTT TTC CAG GAC G 3′
Table 2  Primers for virulence factors of P. aeruginosa 
Gene Primer Nucleotide sequence Reference
toxA Forward 5′ GGA GCG CAA CTA TCC CAC T 3′ Sabharwal et al. (2014); Aghamollaei et al. (2015)
Reverse 5′ TGG TAG CCG ACG AAC ACA TA 3′
aprA Forward 5′ GTC GAC CAG GCG GCG GAG CAG ATA 3′
Reverse 5′ GCC GAG GCC GCC GTA GAG GAT GTC 3′
rhlAB Forward 5′ TCA TGG AAT TGT CAC AAC CGC 3′
Reverse 5′ ATA CGG CAA AAT CAT GGC AAC 3′
lasB Forward 5′ TTC TAC CCG AAG GAC TGA TAC 3′
Reverse 5′ AAC ACC CAT GAT CGC AAC 3′
Table 3  Reference genes for q-PCR
Gene Primer Nucleotide sequence Reference
rpsL Forward 5′ CCT CGT ACA TCG GTG GTG AAG 3′ Pourakbari et al. (2016); Jack et al. (2018)
Reverse 5′ CCC TGC TTA CGG TCT TTG ACAC 3′
AmpC Forward 5′GGT GCA GAA GGA CCA GGC ACA GAT 3′
Reverse 5′CGA TGC TCG GGT TGG AAT AGA GGC 3′
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(0.75 µM), respectively; the assay did not show decrease in 
cell viability of both A549 and HaCaT cell lines (Fig. S1c).
However, MTT assay did reveal a significant decrease in 
cell viability of both the cell lines when grown in co-culture 
with P. aeruginosa sp. (Fig. S2). Overall viability of HaCaT 
cells was found to be lower when compared to A549. In 
order to understand the relevance of these findings, assays 
were performed to identify bacterial adherence patterns to 
the mammalian cell lines as well as the ability of the bacte-
rial cells to internalise into the epithelial cells.
Compared to the control (untreated samples), cell viabil-
ity for both cell lines in co-cultures decreased significantly 
as expected (Fig. S2). A greater reduction in overall cell 
viability was seen with HaCaT cells compared to A549 cells. 
Cell viability for farnesol and tyrosol and in combination 
showed a small decrease in viability but was not found to 
be significant (p = 0.532). Bacterial adherence to A549 and 
HaCaT cell lines was determined by spot plating and by 
determining the ratio between the number of bacterial cells 
in the inoculum to the number of bacteria adhered to the 
mammalian cells. Neither of the strains showed a stronger 
affinity to adhere to the mammalian cells when compared 
to the controls. The main difference, a higher percentage of 
adhesion to HaCaT cells, was observed when compared to 
A549 cells (p = 0.002) as shown in Figure S3; it was prom-
ising to see the antagonistic effect of farnesol and tyrosol 
on reducing adhesion. Greater amount of adherence from 
the CF isolate P. aeruginosa RBHi was expected. However, 
it was not the case and difference in adhesion, based on a 
two-way ANOVA that did not show significance (p = 0.325).
The adherence pattern was found to be similar between 
the three P. aeruginosa strains and the two mammalian cell 
lines used in this study, as seen in Figure S3. Therefore, 
comparison of bacterial internalisation between the two cell 
lines can be beneficial for the infected host as it would most 
likely trigger a quick immune response to combat the infec-
tion during the early stages rather than later stages with an 
established biofilm-based infection (Eisenreich et al. 2013).
Results indicated a higher percentage of internalisation 
compared to adherence of P. aeruginosa sp. onto A549 com-
pared to the HaCaT cell line (Figs. S3 and S4). Dunnett’s 
multiple comparison test (two-way ANOVA) showed that 
the non-mucoid strain P. aeruginosa NCTC 10,662 exhibits 
a lower percentage of internalisation (p = 0.001) compared 
to both PAO1 and the CF isolate RBHi in co-culture with 
A549 cell line as shown in Figure S4a. However, no sig-
nificant decrease or increase in internalisation was observed 
(p = 0.7538) between mucoid and non-mucoid strains against 
HaCaT (Fig. S4b).
Although the internalisation process was inhibited in 
NCTC 10,662 by all the treatments, only the combination 
treatment of farnesol and tyrosol was responsible for a sig-
nificant reduction in internalisation in A549 cells. Upon 
treatment with farnesol, tyrosol and a sub-MIC50 combi-
nation of the two, a decrease in attachment was observed 
amongst all the strains. The highest decrease was seen with 
the non-mucoid strain NCTC 10,662 on the A549 cell line 
with the combination treatment and individual treatment 
alike (p = 0.0001). This indicates that the propensity for P. 
aeruginosa to internalise when grown on A549 cell line is 
more prevalent than adherence during initial colonisation 
when still in planktonic/sessile stage of existence.
This indicates that the potential virulence mechanism of 
internalisation in A549 cells is more prevalent during initial 
colonisation compared to adherence.
P. aeruginosa PAO1 on the HaCaT cells showed a sig-
nificant decrease in attachment with individual treatments 
of farnesol and tyrosol (p = 0.0044) and with combination 
treatment (p = 0.0001) (Fig. S3b). However, only the com-
bination treatment of farnesol and tyrosol was able to elicit 
a significant decrease in bacterial cell internalisation with 
the CF isolate and A549 cell line (Fig. S4a). In comparison, 
a significant decrease in bacterial cell internalisation was 
observed with tyrosol and farnesol, when administered indi-
vidually and when administered in combination specifically 
with the non-mucoid P. aeruginosa NCTC 10,662 (p = 0.021 
and 0.0047, respectively) (Fig. S4a).
Inhibition of P. aeruginosa sp. biofilm formation 
and virulence factor production on A549 and HaCaT 
cell lines by farnesol and tyrosol, individually 
and in combination
Time-point inoculation experiments were performed to 
quantify biofilm formation/inhibition and virulence factor 
production by P. aeruginosa sp. The co-culture medium con-
tained the MIC50 of farnesol and tyrosol relevant to A549 
and HaCaT cells.
CV assay was performed to quantify biofilm formation of 
P. aeruginosa sp. in co-culture with A549 and HaCaT cell 
lines (Supplemental Figs. S5 and S6). Referring to supple-
mental Figure S5, farnesol and tyrosol, individually and in 
combination, have a reduced effect on total biofilm forma-
tion in co-culture when compared to their inhibitory effect 
on just bacterial biofilm formation. The reduced effect can 
be attributed to the  MIC50 of farnesol and tyrosol used for 
co-culture experiments, which are less than those in bacterial 
cultures. Between the two cell lines, biofilms grown on A549 
generally showed a greater EPS content.
Though the addition of farnesol, tyrosol and combi-
nation reduced overall biofilm formation, a significant 
reduction of biofilm formation was observed with the 
addition of combination of farnesol and tyrosol (sub-
MIC) for the non-mucoid, mucoid and heavily mucoid 
strains (p = 0.0001, 0.0036 and 0.0001, respectively); 
P. aeruginosa RBHi showed ~ 26% reduction in total 
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biofilm formation, which was the highest amongst all the 
three strains grown in co-culture. The total carbohydrate 
content of the biofilms in co-culture did not show a sig-
nificant decrease with the addition of farnesol for all the 
three strains. A reduction in alginate content of the EPS 
produced by P. aeruginosa RBHi was seen (p = 0.0012). 
Conversely, tyrosol showed a reduction in total carbohy-
drate content with the RBHi strain without any signifi-
cant reduction in alginate content, when compared to the 
treatment with farnesol. The combination treatment saw 
a significant (p = 0.001) reduction in total carbohydrate 
content to be significant. However, alginate production 
was greatly reduced in PAO1 and RBHi (p = 0.0002 and 
0.0001, respectively). eDNA and protein content on P. 
aeruginosa sp. biofilm remained unaltered with farnesol; 
however, a reduction in protein content was seen with the 
addition of tyrosol to the co-culture with PAO1 and RBHi 
(p = 0.0025 and 0.012, respectively). Combination treat-
ment showed a reduction in eDNA and protein content 
amongst all the strains of P. aeruginosa; however, only the 
reduction in protein content with the combination treat-
ment was found to be significant by a two-way ANOVA 
(p = 0.0167). In comparison, co-culture with HaCaT cells 
showed significantly lower quantity of total biofilm forma-
tion via the CV assay across all P. aeruginosa strains and 
treatments (Supplemental Fig. S6) compared to co-culture 
with A549 (two-way ANOVA, p = 0.0001).
According to supplemental Figure S6, following the 
trend seen in A549 co-culture, the treatments with farnesol, 
tyrosol and combination were found to be more effective in 
inhibiting biofilm formation in co-culture with HaCaT cell 
line, compared to their respective controls. With the excep-
tion of NCTC 10,662, the eDNA and protein content of the 
biofilm produced by the mucoid strain on the HaCaT cell 
line against all three treatments remained identical to the 
control. A similar trend was observed in the total carbohy-
drate content of the biofilm. Tyrosol and combination were 
found to be more effective in reducing total carbohydrate 
content of the biofilm (p = 0.025 and 0.0001, respectively).
Virulence factors such as rhamnolipid, elastolytic activity 
and pyocyanin production were quantified by independent 
assays. Compared to the untreated control, a reduction of 
total virulence was seen with all three treatments involv-
ing farnesol, tyrosol and combination (Fig. 1). Reduction 
of elastolytic activity and pyocyanin production using 
farnesol was significant (p = 0.001 and 0.0001 respectively) 
in P. aeruginosa NCTC 10,662. However, the decrease in 
rhamnolipid production was not significant. Use of tyrosol 
showed a tremendous decrease (p = 0.0001) in rhamnolipid 
production compared to the treatment with farnesol, while 
Fig.1  Virulence factor produc-
tion by P. aeruginosa strains in 
co-culture with A549 cell line 
(n = 5). Error bars represent 
standard deviation
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no significant decrease was seen in elastolytic activity and 
pyocyanin production.
Comparatively in PAO1, all the treatments showed a 
reduction in elastolytic activity and pyocyanin production 
(p = 0.0001), while only the combination treatment showed a 
significant decrease in rhamnolipid production (p = 0.0024), 
and reduction in rhamnolipid production by individual treat-
ments was not significant (p = 0.832). Comparing the indi-
vidual treatments, tyrosol was more effective in reducing 
elastolytic activity and pyocyanin production compared to 
farnesol (p = 0.0001).
P. aeruginosa RBHi was found to be 3 to 4 times more 
virulent compared to PAO1 and NCTC 10,662, respectively, 
and combination treatment showed a significant decrease 
(p = 0.0001) in rhamnolipid production and elastolytic activ-
ity compared to the individual treatments and the control. 
Though pyocyanin production was reduced with the com-
bination treatment compared to the control, it was not sig-
nificant compared to the individual treatments (p = 0.735). 
Overall, the combination treatment involving farnesol and 
tyrosol was more effective against the highly virulent RBHi 
strain when grown in co-culture with A549 cell line.
Quantification and analysis of virulence factors produced 
by P. aeruginosa sp. biofilms grown on HaCaT cell line 
showed a different profile compared to virulence produced 
upon co-culture with A549 cell line. In the non-mucoid 
strain, P. aeruginosa NCTC 10,662, combination treat-
ment with farnesol and tyrosol was found to be the most 
effective at reducing the production of virulence; however, 
all treatments reduced the production of virulence signifi-
cantly (p = 0.0032, Bonferroni post hoc test). In P. aerugi-
nosa PAO1, elastolytic activity and pyocyanin production 
were reduced significantly with all treatments (p = 0.0001); 
however, rhamnolipid production remained at elevated levels 
even though it did reduce in comparison with the control 
(p = 0.002). Overall, treatment with tyrosol and in combina-
tion was found to be more effective (Fig. 2).
The CF isolate P. aeruginosa RBHi showed higher levels 
of virulence when compared to PAO1. These two mucoid 
strains showed a similar trend in decrease of virulence when 
treated with QQs. Reduction of rhamnolipid, pyocyanin and 
elastolytic activity was found to be significant (p = 0.0001) 
when compared to their respective untreated internal con-
trol. However, compared to NCTC 10,662, their virulence 
was elevated.
A549 and HaCaT cells were grown and exposed to bio-
films formed by P. aeruginosa NCTC 10,662, PAO1 and 
RBHi. Time-point inoculation studies also included farnesol 
and tyrosol as individual treatments as well as combination 
treatment to quantify IL-8 secretion by preventing biofilm 
Fig.2  Virulence factor produc-
tion by P. aeruginosa strains 
in co-culture with HaCaT cell 
line (n = 5). Error bars represent 
standard deviation
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formation. From ELISA, it was found that there was an 
increase in IL-8 secretion by A549 cells, which increased in 
the presence of biofilm formed by P. aeruginosa (Fig. 3a). 
The exogenous addition of farnesol and tyrosol and com-
bination to combat biofilm formation did show a reduced 
IL-8 secretion. In the case of NCTC 10,662, the reduction in 
IL-8 production when treated with farnesol was found to be 
significant (p = 0.044), while the others were not found to be 
significant. In the case of HaCaT cells, reduction of IL-8 was 
not observed under any set of treatments with all the three 
P. aeruginosa strains (Fig. 3b). However, the basal level of 
IL-8 secretion for both the cell lines (A549 and HaCaT) 
was very low in the absence of stimulation along with low 
levels of apoptosis. This is generally expected of cell lines 
and was therefore found suitable as mammalian cell models 
for this study.
Production of IL-8 by HaCaT and A549 cells in the pres-
ence of P. aeruginosa and also when treated with farnesol 
and tyrosol individually and in combination was not signifi-
cant (Fig. 3).
Following farnesol, tyrosol and combination treatment 
of P. aeruginosa PAO1 biofilm in co-culture with A549 and 
HaCaT cell lines, the LasI/R and RhlI/R genes were sig-
nificantly upregulated compared to the control (Fig. 4a, c). 
Comparing the two cell lines, co-culture with HaCaT cell 
line showed a significantly higher LasI/R and RhlI/R upregu-
lation compared to co-culture on A549 cell line. While com-
bination of farnesol + tyrosol combination induced a signifi-
cant upregulation of LasR and RhlI on A549 cells, individual 
treatment with tyrosol was responsible for upregulation of 
LasI and RhlR (Fig. 4a). Co-culture of PAO1 with A549 
cell line treated with farnesol showed a downregulation of 
toxA, aprA, rhlAB and lasB virulence. However, tyrosol and 
combination treatment showed a tremendous upregulation 
of rhlAB in PAO1 co-culture with A549 cell line (Fig. 4b), 
while all others were downregulated with tyrosol and com-
bination treatment. Individual treatment with farnesol down-
regulated LasR in co-culture with A549 cell line. Combina-
tion treatment with farnesol + tyrosol showed a consistent 
and significant upregulation of LasI/R and RhlI/R of PAO1 
in co-culture with HaCaT cell line (Fig. 4c). Individual treat-
ment with farnesol and tyrosol showed significant upregula-
tion of LasI/R and RhlI/R on HaCaT cell line. In the case of 
co-culture with HaCaT cell line (Fig. 4d), aprA and rhlAB 
were downregulated with all the treatments, while tyrosol 
induced an upregulation of toxA and lasB and combination 
of farnesol and tyrosol upregulated toxA.
Gene expression of P. aeruginosa NCTC 10,662 in co-
culture with A549 cell line showed an upregulation of RhlI 
and RhlR when treated with tyrosol and combination of 
farnesol and tyrosol, while farnesol downregulated RhlI and 
RhlR (Fig. 5a). Conversely, farnesol upregulated LasI and 
LasR marginally, while treatment with tyrosol and combina-
tion downregulated LasI and LasR. With the exception of 
upregulation of rhlAB (combination treatment), all the other 
virulence factors were downregulated in co-culture with 
A549 (Fig. 5b). Co-culture of NCTC 10,662 on HaCaT cell 
line with treatment showed a consistent downregulation of 
LasI/R, RhlI/R and the virulence factors (Fig. 5c, d).
Upregulation of LasI/R and RhlI/R was seen with tyrosol 
treatment of RBHi co-culture with A549 cell line (Fig. 6a), 
while the other treatments showed a pattern of downregula-
tion. Individual treatment of farnesol and tyrosol showed 
an upregulation of toxA and rhlAB, while tyrosol also con-
tributed to the upregulation of lasB. Combination treatment 
was responsible for upregulation of rhlAB. aprA remained 
the only virulence factor that was downregulated under 
Fig.3  P. aeruginosa sp. biofilm formation stimulates significantly 
increased levels of IL-8 release, compared to the control, in a A549 
cells when exposed to biofilm formation and treatment with farnesol 
and tyrosol and in b HaCaT cells when exposed to biofilm formation 
and treatment with farnesol and tyrosol. Secreted IL-8 was measured 
by ELISA (n = 3). Error bars represent standard deviation
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Fig.4  mRNA expression of 
AHL-mediated QS circuit and 
virulence factors in P. aerugi-
nosa PAO 1 sessile cells grown 
with QQ. The fold change of 
mRNA for QS and virulence 
genes was determined for P. 
aeruginosa PAO1 sessile cells 
extracted from biofilm treated 
with farnesol and tyrosol 
after ~ 16 h growth. Results 
are expressed as the mean fold 
change (control standardised to 
1.0) with error bars representing 
SEM (n = 9). Error bars repre-
sent standard deviation
Fig.5  mRNA expression of 
AHL mediated QS circuit in 
P. aeruginosa NCTC 10,662 
sessile cells grown with QQ. 
The fold change of mRNA for 
QS and virulence factors genes 
was determined for P. aer-
uginosa NCTC 10,662 sessile 
cells extracted from biofilm 
treated with farnesol and tyrosol 
after ~ 16 h growth. Results 
are expressed as the mean fold 
change (control standardised to 
1.0) with error bars representing 
SEM (n = 9). Error bars repre-
sent standard deviation
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combination treatment (Fig. 6b). With the exception of 
RhlI, which was upregulated in the co-culture of RBHi and 
HaCaT, all the other genes were downregulated (Fig. 6c, d).
Discussion
At present, there is no clear study that investigates the behav-
iour of different phenotypes of P. aeruginosa in the presence 
of biotic surfaces, which the bacterium is known to infect. 
This research lays the grounds for examining the host–patho-
gen interactions of three P. aeruginosa phenotypes on two 
different epithelial cell lines they may infect. Additionally, 
each strain can have different responses to environmental 
stimuli, such as antagonist chemicals that inhibit biofilm 
formation and composition. Spot-plating experiments on 
bacterial adherence to A549 and HaCaT cell lines indicated 
that treatments containing a combination of farnesol and 
tyrosol significantly decreased bacterial adherence relative 
to the control (Fig. S3). This decreased adherence may be 
attributed to the secretion of exotoxins by the type III secre-
tion system, whereby the primary function is to damage epi-
thelial cells which leads to cytoskeletal rearrangement and 
results in cell lysis during the planktonic and initial colonisa-
tion stage of P. aeruginosa (Galle et al. 2012).
P. aeruginosa PAO1 adhesion to and invasion of A549 
lung epithelial cells was examined by Ahmed et al. (2014) 
using anti-adhesion natural extracts (cranberry, dextran 
and soybean extracts) in combination with an antibiotic, 
ciprofloxacin. Their research found that when dextran and 
ciprofloxacin were combined, approximately 85% of the bac-
teria that adhered in the control experiments were unable 
to internalise. The combination of cranberry extract and 
ciprofloxacin sub-MIC inhibited the early stages of infec-
tion, i.e., adhesion and invasion, and decreased subsequent 
growth of bacteria. In the case of ciprofloxacin combined 
with soybean extract, 28% and 12% of the applied bacte-
rial inoculum could adhere to and invade the lung epithelial 
cells, respectively, compared to the control.
Farnesol inhibits the synthesis of quorum sensing mole-
cule (QSM), 2-heptyl-3-hydroxy-4-quinolone (Pseudomonas 
quinolone signal: PQS), bacterial swarming motility (McA-
lester et al. 2008) and PQS-regulated virulence factor pyo-
cyanin (Cugini et al., 2007) in P. aeruginosa. PQS has been 
shown also to play a role in the development of P. aerugi-
nosa biofilms. As a result, Bandara et al., (2016) hypoth-
esised that farnesol inhibits P. aeruginosa biofilm growth. 
Based on our study, it is clear that farnesol and tyrosol dis-
play an inhibitory effect on the QS circuitry of P. aeruginosa 
as the PQS QS system is regulated by LasR and RhlR in 
tandem (Kostylev et al. 2019). This translates to reduced 
biofilm formation as depicted by reduced production of the 
various biopolymers that make up the biofilm (Supplemental 
Figs. S5 and S6). When in co-culture with the A549 and 
HaCaT cell lines, the formation of biofilm differed consider-
ably along with the expression of QS and virulence genes. 
It is important to note that, when treated with farnesol and 
tyrosol, the CF isolate (RBHi) showed significantly reduced 
levels of gene expression in co-culture with HaCaT cells in 
comparison to co-culture with A549 cells. Although A549 
Fig.6  mRNA expression of 
AHL-mediated QS circuit in 
P. aeruginosa RBHi sessile 
cells grown with QQ. The fold 
change of mRNA for QS and 
virulence genes was determined 
for P. aeruginosa RBHi sessile 
cells (Kalgudi 2019) treated 
with farnesol and tyrosol 
after ~ 16 h growth. Results 
are expressed as the mean fold 
change (control standardised to 
1.0) with error bars representing 
SEM (n = 9). Error bars repre-
sent standard deviation
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cells are not an exact representative of CF, the CF isolate 
shows a highly pathogenic nature when compared to co-
culture with HaCaT cells. In co-culture with the HaCaT 
cell lines (Supplemental Fig. S6), nearly ~ 75% reduction of 
biofilm was seen using combination treatment (p = 0.0001) 
against NCTC 10,662. Approximately 25% reduction was 
observed with RBHi (p = 0.0002) and ~ 45% reduction with 
PAO1 (p = 0.0027). However, farnesol-inhibited biofilm for-
mation was not significant (p = 0.325). On the other hand, 
inhibition of biofilm formation under tyrosol and combina-
tion of the two QQ agents were significant (p = 0.023 and 
0.0002, respectively) (Supplemental Fig. S6). The eDNA 
and protein content of the biofilm produced by the mucoid 
strain on the HaCaT cell line against all three treatments 
remained identical to the control, with the exception of 
NCTC 10,662, which appeared to be affected by the combi-
nation treatment, showing a 40% reduction (p = 0.0028) in 
eDNA content and a 30% reduction (p = 0.001) in protein 
content of the biofilm. Furthermore, the reduction in eDNA 
and protein content was not found to be significant when 
compared between farnesol and tyrosol. When RBHi was 
treated with a combination of farnesol and tyrosol, reduc-
tion in carbohydrate content (55%) was observed. With the 
combined treatment, RBHi was also the only strain to exhibit 
an 18% decrease in alginate content (p = 0.034). Comparing 
the two cell lines (Supplemental Figs. S5 and S6), all the 
phenotypes of P. aeruginosa demonstrated a stronger affin-
ity towards A549 cell line compared to HaCaT cell line, 
as shown by its ability to form biofilms and secrete EPS. 
Overall, farnesol and tyrosol combined treatment was more 
successful against P. aeruginosa biofilm. However, tyrosol 
was the most successful of the individual treatments.
Figure  3 a and b reveal that a higher rate of pro-
inflammatory effect is achieved when bacterial cells are 
in contact with HaCaT cells when compared with A549. 
This also indicates the sensitivity of HaCaT cells towards 
inflammatory agents, compared to A549 cells. The produc-
tion of IL-8 by the epithelial cells is an important indica-
tor of host response and production of IL-8 is generally 
associated with acute and chronic infections. There is lit-
tle data comparing IL-8 secretion by two different cell 
lines when exposed to biofilm formed by P. aeruginosa; 
comparative data on IL-8 secretion as an inflammatory 
response in co-culture with three distinct strains of biofilm 
forming P. aeruginosa is lacking. In the case of NCTC 
10,662, the reduction in IL-8 output after treatment with 
farnesol was found to be significant, while the others were 
not. This may be due to the static nature of the co-culture, 
as well as the fact that farnesol and tyrosol are both QS 
molecules found in fungi. As a result, they can cause a 
similar reaction and increase IL-8 secretion by epithelial 
cells. Low amounts, on the other hand, did not result in an 
increase in IL-8 output. The static growth model of this 
assay limits its ability to explain the antagonistic effect 
of farnesol and tyrosol in combination treatment. To test 
the effect of farnesol and tyrosol on P. aeruginosa biofilm 
inhibition, a flow model, similar to a microfluidic chip, or 
a robust co-culture model using 3D tissue culture of mam-
malian cells should be used.
Both adhesion and formation of biofilms depend pri-
marily on motility (Sun et al., 2017). Swimming, swarm-
ing and twitching are three forms of motility in P. aer-
uginosa that are positively controlled by the LasIR and 
RhIR QS systems; las regulating swimming, swarming 
and twitching; and rhI controlling swarming and twitch-
ing (Yeung et al., 2009). Abdel-Rhman et al., (2020) found 
that tyrosol (1/4 ×—1/16 × MIC) significantly decreased 
both swimming and swarming motility, but had no effect 
on twitching motility. Our study shows that regulation of 
gene expression differs significantly between strains and 
in the presence of similar treatments (QQ) (Figs. 5 and 
6). This is evident in varying levels of gene expression 
seen for LasI/R and Rhll/R. Expression of virulence pro-
gressively increases with increase in mucoidity of P. aer-
uginosa. This is in parallel with developed P. aeruginosa 
biofilms and chronic infections.
The study of gene expression levels of bacterial com-
munication and virulence production in a host–pathogen 
model has contributed to the current understanding of the 
creation of potential novel therapies. Future modifications 
to this model can better reflect in vivo infection conditions, 
allowing researchers to better define host–pathogen inter-
actions and develop new therapeutic regimens to combat 
biofilm formation.
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